Ceo's Speech 2014

Dear Colleagues,

Happy new year to you all. I hope you celebrated the start of 2014 in good spirits with family and friends. Now that we just passed a few days of the new year, it’s good to look ahead and think about what this year may bring us. But first, a quick look back. 2013 was quite a year for all of us at SUMMIT. We’ve been through many developments, in sometimes less than favourable circumstances. But we’ve also achieved a huge amount. Within automatic analyzer and reagents of clinical chemistry business we have made good progress: twenty new customers, getting upsales from our current clinical laboratories customers, successfully launching our new product line of chemistry reagent, and finalizing registration process at Ministry of Health of Republic of Indonesia for our future signature product which is new biomarker for monitoring diabetes, glycated albumin reagent. Within Medical Information System business, we have launched the new sales and system implementation strategy of our Laboratory Information System TD-Synergy and carefully cuted on it throughout the year. In several customers, we got upsales of new LIS modules such as Microbiology Module, Histology-Cytology Module, Blood Bank Module, and Web Module for Specimen Collection, Request and Result Management. We also had just signed a cooperation agreement as local partner for one of the top world wide Radiology Information System NovaRad. By having LIS and RIS in our product line will definitely upgrade our value proposition to clinical laboratories and hospitals. Within our new coagulation reagent business, we have reached significant milestone through some researches collaborating with wellknown Clinical Pathologists in some education centers of Clinical Pathologist Department such as at Medical Faculty of University of Indonesia and Medical Faculty of University of Padjajaran. Of course, there’s still a lot of work ahead. As you might have known, starting the first of January of 2014, the...